A detailed history of Benjamin Edwards Inc transactions in Haleon PLC stock. As of the latest transaction made, Benjamin Edwards Inc holds 76,051 shares of HLN stock, worth $737,694. This represents 0.01% of its overall portfolio holdings.

Number of Shares
76,051
Holding current value
$737,694
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.32 - $10.7 $632,744 - $813,745
76,051 New
76,051 $804,000
Q4 2023

Feb 06, 2024

BUY
$7.78 - $8.62 $1,167 - $1,292
150 New
150 $1,000
Q1 2023

Apr 27, 2023

SELL
$7.57 - $8.37 $1,120 - $1,238
-148 Reduced 51.03%
142 $1,000
Q3 2022

Oct 28, 2022

BUY
$5.63 - $7.5 $1,632 - $2,175
290 New
290 $2,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.